In vitro validation studies for adhesion factor and adhesion efficiency of probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 on HT-29 cell lines
- PMID: 33772601
- DOI: 10.1007/s00203-021-02257-y
In vitro validation studies for adhesion factor and adhesion efficiency of probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 on HT-29 cell lines
Abstract
Probiotic bacterial adhesion to the epithelial cell is a composite process and in vivo adhesion studies can be strengthened with the improved in vitro models for preliminary screening of potentially adherent strains. With this rationale, the study aimed is the first report to demonstrate the colonizing efficiency of probiotic Bacillus licheniformis MCC 2514 in comparison to Bifidobacterium breve NCIM 5671on HT-29 cell line. B. licheniformis (54.28 ± 0.99%) and Bif. breve (70.23 ± 0.85%) adhered in a higher percentage on fibronectin and mucin, respectively. However, the adhesion was higher for B. licheniformis when compared to Bif. breve. In adhesion score, B. licheniformis obtained about 138.85 ± 12.32, whereas Bif. breve got the score of 43.05 ± 9.12. The same trend continued in the adhesion percentage study, where B. licheniformis adhered 75.5 ± 5.2%, higher than Bif. breve which adhered 32.66 ± 3.2%. In invasion assay, both the bacteria significantly decreased the colonization of the pathogen Kocuria rhizophila ATCC 9341 about 97.32 ± 0.81% in the competitive assay, 97.87 ± 0.73% in exclusion assay and 82.19 ± 2.51% in displacement assay. The cytotoxicity effects of the test bacterial strains against HT-29 cell line through MTT assay determined no viability loss in the treated cells. Therefore, the data obtained from the in vitro studies showed that both B. licheniformis and Bif. breve had shown significantly good invasion on pathogen and adhesion capacity on HT-29 cell line.
Keywords: Adhesion; Bacillus; Bifidobacteria; Health benefits; Invasion; Probiotics.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Probiotic Bacillus licheniformis MCC2514 and Bifidobacterium breve NCIM 5671 Regulates GATA3 and Foxp3 Expression in the Elevated Disease Condition.Probiotics Antimicrob Proteins. 2023 May 17. doi: 10.1007/s12602-023-10080-8. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37195508
-
The Combined Effect of Potential Probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 Towards Anti-inflammatory Activity on HT-29 Cell Lines.Probiotics Antimicrob Proteins. 2023 Apr;15(2):351-362. doi: 10.1007/s12602-021-09851-y. Epub 2021 Sep 28. Probiotics Antimicrob Proteins. 2023. PMID: 34581975
-
Preparation of Bifidobacterium breve encapsulated in low methoxyl pectin beads and its effects on yogurt quality.J Dairy Sci. 2019 Jun;102(6):4832-4843. doi: 10.3168/jds.2018-15597. Epub 2019 Apr 10. J Dairy Sci. 2019. PMID: 30981490
-
Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.Asia Pac J Clin Nutr. 2006;15(4):570-5. Asia Pac J Clin Nutr. 2006. PMID: 17077078 Review.
-
Potential application of the probiotic Bacillus licheniformis as an adjuvant in the treatment of diseases in humans and animals: A systematic review.Front Microbiol. 2022 Sep 26;13:993451. doi: 10.3389/fmicb.2022.993451. eCollection 2022. Front Microbiol. 2022. PMID: 36225361 Free PMC article. Review.
Cited by
-
Genome mining of Bacillus licheniformis MCC2514 for the identification of lasso peptide biosynthetic gene cluster and its characterization.Arch Microbiol. 2024 Mar 5;206(4):143. doi: 10.1007/s00203-024-03877-w. Arch Microbiol. 2024. PMID: 38443732
-
Identification and evaluation of probiotic potential of Bifidobacterium breve AHC3 isolated from chicken intestines and its effect on necrotizing enterocolitis (NEC) in newborn SD rats.PLoS One. 2023 Nov 2;18(11):e0287799. doi: 10.1371/journal.pone.0287799. eCollection 2023. PLoS One. 2023. PMID: 37917716 Free PMC article.
-
Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications.Pharmaceutics. 2023 Jul 5;15(7):1893. doi: 10.3390/pharmaceutics15071893. Pharmaceutics. 2023. PMID: 37514078 Free PMC article. Review.
-
Probiotic Bacillus licheniformis MCC2514 and Bifidobacterium breve NCIM 5671 Regulates GATA3 and Foxp3 Expression in the Elevated Disease Condition.Probiotics Antimicrob Proteins. 2023 May 17. doi: 10.1007/s12602-023-10080-8. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37195508
-
Dietary Bacillus licheniformis shapes the foregut microbiota, improving nutrient digestibility and intestinal health in broiler chickens.Front Microbiol. 2023 Feb 10;14:1113072. doi: 10.3389/fmicb.2023.1113072. eCollection 2023. Front Microbiol. 2023. PMID: 36846755 Free PMC article.
References
-
- Achi SC, Halami PM (2019) In vitro comparative analysis of probiotic and functional attributes of indigenous isolates of Bifidobacteria. Curr Microbiol 76:304–311. https://doi.org/10.1007/s00284-018-1615-9 - DOI - PubMed
-
- Archer AC, Halami PM (2015) Probiotic attributes of Lactobacillus fermentum isolated from human feces and dairy products. Appl Microbiol Biotechnol 99:8113–8123. https://doi.org/10.1007/s00253-015-6679-x - DOI - PubMed
-
- Ayala FR, Bauman C, Bartolini M et al (2017) Transcriptional regulation of adhesive properties of Bacillus subtilis to extracellular matrix proteins through the fibronectin-binding protein YloA. Mol Microbiol 104:804–821. https://doi.org/10.1111/mmi.13666 - DOI
-
- Azimirad M, Alebouyeh M, Naji T (2017) Inhibition of lipopolysaccharide-induced interleukin 8 in human adenocarcinoma cell line HT-29 by spore probiotics: B. coagulans and B. subtilis (natto). Probiotics Antimicrob Proteins 9:56–63. https://doi.org/10.1007/s12602-016-9234-x - DOI - PubMed
-
- Baccigalupi L, Di A, Parlato M et al (2005) Small surface-associated factors mediate adhesion of a food-isolated strain of Lactobacillus fermentum to Caco-2 cells. Res Microbiol 156:830–836. https://doi.org/10.1016/j.resmic.2005.05.001 - DOI - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
